These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9652052)

  • 1. Differentiating infection from vaccination in foot-and-mouth disease.
    Mackay DK
    Vet Q; 1998; 20 Suppl 2():S2-5. PubMed ID: 9652052
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of cattle exposed to foot-and-mouth disease virus by means of an indirect ELISA test using bioengineered nonstructural polyprotein 3ABC.
    Malirat V; Neitzert E; Bergmann IE; Maradei E; Beck E
    Vet Q; 1998; 20 Suppl 2():S24-6. PubMed ID: 9652059
    [No Abstract]   [Full Text] [Related]  

  • 3. An Australian perspective of foot-and-mouth disease research.
    Forman AJ
    Aust Vet J; 1989 Dec; 66(12):409-10. PubMed ID: 2559692
    [No Abstract]   [Full Text] [Related]  

  • 4. Serodiagnostic strategy for estimation of foot-and-mouth disease viral activity through highly sensitive immunoassays using bioengineered nonstructural proteins.
    Bergmann IE; Astudillo V; Malirat V; Neitzert E
    Vet Q; 1998; 20 Suppl 2():S6-9. PubMed ID: 9652053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neutralizing and protecting antibodies in the serum cattle vaccinated against foot and mouth disease].
    Brunengo AM; Díaz Primerano AM; Peso OA
    Rev Asoc Argent Microbiol; 1977; 9(3):115-25. PubMed ID: 208108
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins.
    Mezencio JM; Babcock GD; Meyer RF; Lubroth J; Salt JS; Newman JF; Brown F
    Vet Q; 1998; 20 Suppl 2():S11-3. PubMed ID: 9652055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking ELISAs using the FMDV non-structural proteins 3D, 3AB, and 3ABC produced in the baculovirus expression system.
    Sørensen KJ; Hansen CM; Madsen ES; Madsen KG
    Vet Q; 1998; 20 Suppl 2():S17-20. PubMed ID: 9652057
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenge of vaccinated pigs with foot-and-mouth disease virus.
    de Leeuw PW; Tiessink JW; van Bekkum JG
    Zentralbl Veterinarmed B; 1979 Mar; 26(2):98-109. PubMed ID: 231356
    [No Abstract]   [Full Text] [Related]  

  • 9. Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations.
    Lubroth J; López A; Ramalho AK; Meyer RF; Brown F; Darsie GC
    Vet Q; 1998; 20 Suppl 2():S13-7. PubMed ID: 9652056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of immunity in swine inoculated with a monovalent foot-and-mouth disease oil emulsion vaccine.
    Buonavoglia C; di Trani L; Gramenzi F; Zoletto R; Lelli R; Scacchia M
    Zentralbl Veterinarmed B; 1988 Jul; 35(6):397-401. PubMed ID: 2847446
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody to the nonstructural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection.
    Mackay DK; Forsyth MA; Davies PR; Salt JS
    Vet Q; 1998; 20 Suppl 2():S9-11. PubMed ID: 9652054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Foot-and-mouth disease in buffaloes (Bubalus bubalis, Linnaeus, 1758): search of antiantigen antibodies and isolation of the virus].
    Jerez JA; Pinto AA; Arruda NV; Koseki I; Abuhab TG; Rodrigues MA
    Arq Inst Biol (Sao Paulo); 1979; 46(3-4):111-5. PubMed ID: 233417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foot-and-mouth disease: a vaccine study.
    McKercher PD; Callis JJ
    Dev Biol Stand; 1976; 35():123-33. PubMed ID: 198278
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses of sheep against inactivated foot-and-mouth disease PEG concentrated aluminium hydroxide gel vaccines.
    Nair SP; Sen AK
    Trop Anim Health Prod; 1994 Nov; 26(4):255-7. PubMed ID: 7900227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of vaccination against foot-and-mouth disease on results of the immunodiffusion test for the demonstration of precipitating bovine leukosis virus antibodies].
    Straub OC
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):135-7. PubMed ID: 6305624
    [No Abstract]   [Full Text] [Related]  

  • 16. ['Tomorrow we start vaccination, that is our duty'].
    Scholma-van der Perk D
    Tijdschr Diergeneeskd; 2001 Jun; 126(11):406. PubMed ID: 11417083
    [No Abstract]   [Full Text] [Related]  

  • 17. Difference in protective immunity of the tongue and feet of guinea pigs vaccinated with foot-and-mouth disease virus type A12 following intradermolingual and footpad challenge.
    Knudsen RC; Groocock CM; Andersen AA
    Vet Microbiol; 1982 May; 7(2):97-107. PubMed ID: 6287702
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the Relationship between immunity and the level of neutralizing antibodies in pigs vaccinated against foot-and-mouth disease (author's transl)].
    Bauer K; Lorenz RJ; Wittmann G
    Arch Virol; 1975; 49(4):349-57. PubMed ID: 174529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell mediated immunity to foot and mouth disease virus vaccine in buffaloes.
    Rahman MM; Prasad S; Sharma R
    Indian J Exp Biol; 1987 Jun; 25(6):360-2. PubMed ID: 2831140
    [No Abstract]   [Full Text] [Related]  

  • 20. An experimental subunit vaccine for foot-and-mouth disease.
    Bachrach HL; Moore DM; McKercher PD; Polatnick J
    Dev Biol Stand; 1976; 35():155-60. PubMed ID: 198282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.